The authors hypothesized that, during contraction, fluxes through nucleotidases might be too reduced to influence AMP levels and concluded that pharmacological inhibition of AMP-metabolizing enzymes might not be useful for promoting AMPK activation and glucose uptake in muscle of type-2 diabetic patients. This evidence concerns the gene PRKAA2 and type 2 diabetes mellitus.